These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14711892)

  • 1. Persistent airway inflammation after resolution of respiratory syncytial virus infection in rats.
    Piedimonte G; Hegele RG; Auais A
    Pediatr Res; 2004 Apr; 55(4):657-65. PubMed ID: 14711892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A humanized monoclonal antibody against respiratory syncytial virus (palivizumab) inhibits RSV-induced neurogenic-mediated inflammation in rat airways.
    Piedimonte G; King KA; Holmgren NL; Bertrand PJ; Rodriguez MM; Hirsch RL
    Pediatr Res; 2000 Mar; 47(3):351-6. PubMed ID: 10709734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exaggerated neurogenic inflammation and substance P receptor upregulation in RSV-infected weanling rats.
    King KA; Hu C; Rodriguez MM; Romaguera R; Jiang X; Piedimonte G
    Am J Respir Cell Mol Biol; 2001 Feb; 24(2):101-7. PubMed ID: 11159042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of respiratory syncytial virus on apnea in weanling rats.
    Sabogal C; Auais A; Napchan G; Mager E; Zhou BG; Suguihara C; Bancalari E; Piedimonte G
    Pediatr Res; 2005 Jun; 57(6):819-25. PubMed ID: 15774838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of neuroimmune mechanisms to airway inflammation and remodeling during and after respiratory syncytial virus infection.
    Piedimonte G
    Pediatr Infect Dis J; 2003 Feb; 22(2 Suppl):S66-74; discussion S74-5. PubMed ID: 12671455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A guinea pig model of respiratory syncytial virus infection for cough and its neurogenic inflammatory mechanism].
    Ye XM; Zhong NS; Liu CL; Zhao J; Qin S; Chen RC
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1708-12. PubMed ID: 21914323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats.
    Wyde PR; Moore DK; Hepburn T; Silverman CL; Porter TG; Gross M; Taylor G; Demuth SG; Dillon SB
    Pediatr Res; 1995 Oct; 38(4):543-50. PubMed ID: 8559607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New strategies for control of respiratory syncytial virus infection.
    Nokes JD; Cane PA
    Curr Opin Infect Dis; 2008 Dec; 21(6):639-43. PubMed ID: 18978532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of motavizumab, an ultra-potent antibody for the prevention of respiratory syncytial virus infection in the upper and lower respiratory tract.
    Wu H; Pfarr DS; Johnson S; Brewah YA; Woods RM; Patel NK; White WI; Young JF; Kiener PA
    J Mol Biol; 2007 May; 368(3):652-65. PubMed ID: 17362988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus upregulates expression of the substance P receptor in rat lungs.
    Piedimonte G; Rodriguez MM; King KA; McLean S; Jiang X
    Am J Physiol; 1999 Oct; 277(4):L831-40. PubMed ID: 10516226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Respiratory syncytial virus persistence: evidence in the mouse model.
    Mejías A; Chávez-Bueno S; Gómez AM; Somers C; Estripeaut D; Torres JP; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2008 Oct; 27(10 Suppl):S60-2. PubMed ID: 18820580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanobodies® specific for respiratory syncytial virus fusion protein protect against infection by inhibition of fusion.
    Schepens B; Ibañez LI; De Baets S; Hultberg A; Bogaert P; De Bleser P; Vervalle F; Verrips T; Melero J; Vandevelde W; Vanlandschoot P; Saelens X
    J Infect Dis; 2011 Dec; 204(11):1692-701. PubMed ID: 21998474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylaxis in RSV infection (Palivizumab)--is it worthwhile?
    Hashmi NA; Cosgrove JF; MacMahon P
    Ir Med J; 2000 Dec; 93(9):284. PubMed ID: 11209917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats.
    Auais A; Adkins B; Napchan G; Piedimonte G
    Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L105-13. PubMed ID: 12639840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats.
    Zhao X; Chen FP; Sullender WM
    Virology; 2004 Jan; 318(2):608-12. PubMed ID: 14972528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-inflammatory effect of albuterol enantiomers during respiratory syncytial virus infection in rats.
    Auais A; Wedde-Beer K; Piedimonte G
    Pediatr Pulmonol; 2005 Sep; 40(3):228-34. PubMed ID: 15957175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Passive IgA monoclonal antibody is no more effective than IgG at protecting mice from mucosal challenge with respiratory syncytial virus.
    Fisher RG; Crowe JE; Johnson TR; Tang YW; Graham BS
    J Infect Dis; 1999 Oct; 180(4):1324-7. PubMed ID: 10479165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group.
    Pediatrics; 1998 Sep; 102(3 Pt 1):531-7. PubMed ID: 9738173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Palivizumab is highly effective in suppressing respiratory syncytial virus in an immunosuppressed animal model.
    Ottolini MG; Curtis SR; Mathews A; Ottolini SR; Prince GA
    Bone Marrow Transplant; 2002 Jan; 29(2):117-20. PubMed ID: 11850705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of the first dose of palivizumab immunoprophylaxis against respiratory syncytial virus in infants before hospital discharge: what is the evidence for its benefit?
    Geskey JM; Ceneviva GD; Brummel GL; Graff GR; Javier MC
    Clin Ther; 2004 Dec; 26(12):2130-7. PubMed ID: 15823776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.